pdCas9-DNMT3A-PuroR_hNT Citations (3)

Originally described in: Repurposing the CRISPR-Cas9 system for targeted DNA methylation.
Vojta A, Dobrinic P, Tadic V, Bockor L, Korac P, Julg B, Klasic M, Zoldos V Nucleic Acids Res. 2016 Mar 11. pii: gkw159. PubMed Journal

---

Articles Citing pdCas9-DNMT3A-PuroR_hNT

Articles
Hypoxia-induced CTCF promotes EMT in breast cancer. Kakani P, Dhamdhere SG, Pant D, Joshi R, Mishra J, Samaiya A, Shukla S. Cell Rep. 2024 Jul 23;43(7):114367. doi: 10.1016/j.celrep.2024.114367. Epub 2024 Jun 18. PubMed
Hypoxia-induced CTCF mediates alternative splicing via coupling chromatin looping and RNA Pol II pause to promote EMT in breast cancer. Kakani P, Dhamdhere SG, Pant D, Joshi R, Mishra S, Pandey A, Notani D, Shukla S. Cell Rep. 2025 Feb 25;44(2):115267. doi: 10.1016/j.celrep.2025.115267. Epub 2025 Feb 4. PubMed
PRMT5 regulates alternative splicing of TCF3 under hypoxia to promote EMT and invasion in breast cancer. Mutnuru SA, Yadav P, Kakani P, Dhamdhere SG, Kumari P, Agrawal S, Samaiya A, Shukla S. PLoS Biol. 2025 Oct 28;23(10):e3003444. doi: 10.1371/journal.pbio.3003444. eCollection 2025 Oct. PubMed

If you have published an article using this material, please email us at to have your article added to this page.